XUANZHUBIO-B
0257518AListed醫療健康 · 轩竹生物是一家专注于创新药物研发的生物科技公司。
High attention
83.6
/100
- Offer price
- HK$11.60
- Final offer price
- HK$11.60
- Lot / entry fee
- 500 shares · HK$6K
- Proceeds
- HK$781.1M
- Sponsor
- CICC
- Est. margin oversub.
- 3961.0x
- Public oversub.
- 4908.3x
- One-lot win rate
- 1.0%
- First-day return
- +126.7%
Offer starts
Oct 6
Offer closes
Oct 10
Grey market
Oct 14
Listing
Oct 15
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
83.6/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Strong positivePartial basis
Up probability
85.4%
First-day reference range
+161.2% – +244.9%
Published outcome check
First-day resultBig up+126.7%
Our call: Trend call valid
Covered 16/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Strong trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Average qualityGrowth quality
Average qualityProfitability
Weak qualityCash runway
High qualityCustomer concentration
—Cornerstone quality
—Sponsor record
Strong recordGreenshoe arrangementNo greenshoe
Stabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.